PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.28%
10Y revenue/share CAGR above 1.5x JHX's 24.09%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
38.89%
3Y revenue/share CAGR 1.25-1.5x JHX's 32.78%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
113.04%
3Y OCF/share CAGR at 50-75% of JHX's 152.23%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-28.72%
Negative 10Y net income/share CAGR while JHX is at 183.93%. Joel Greenblatt sees a major red flag in long-term profit erosion.
No Data
No Data available this quarter, please select a different quarter.
528.84%
3Y net income/share CAGR 50-75% of JHX's 756.09%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
0.03%
Positive growth while JHX is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
No Data
No Data available this quarter, please select a different quarter.
8.49%
Positive short-term equity growth while JHX is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.48%
Negative near-term dividend growth while JHX invests at 22.57%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.